Edition:
United Kingdom

Endo International PLC (ENDP.OQ)

ENDP.OQ on NASDAQ Stock Exchange Global Select Market

8.33USD
22 Mar 2019
Change (% chg)

$-0.43 (-4.91%)
Prev Close
$8.76
Open
$8.67
Day's High
$8.78
Day's Low
$8.19
Volume
1,322,059
Avg. Vol
1,108,776
52-wk High
$18.50
52-wk Low
$5.28

Select another date:

Fri, Mar 1 2019

Endo gains on favorable FDA drug compounding decision

Endo International Plc said on Friday the U.S. health regulator has decided https://bit.ly/2XGrm1k not to include blood pressure treatment vasopressin in its list of drugs that can be used in compounding, in a boost to the drugmaker that makes the only FDA-approved version of the product.

Endo gains on favorable FDA drug compounding decision

March 1 Endo International Plc said on Friday the U.S. health regulator has decided https://www.fda.gov/NewsEvents/Newsroom/FDAInBrief/ucm632432.htm?utm_campaign=Compounding:%20FDA%20finalizes%20guidance%20on%20evaluating%20the%20clinical%20need%20for%20outsourcing&utm_medium=email&utm_source=Eloqua not to include blood pressure treatment vasopressin in its list of drugs that can be used in compounding, in a boost to the drugmaker that makes the only FDA-approved version of the produ

Select another date: